YOLFTbeta
HLscience Co. Ltd

HLscience Co. Ltd

239610 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

6,100.00KRW+110.00 (+1.84%)

Price History

Full chart

Market Stats

Previous Close5,990.00
Open5,960.00
Day Range5,930.00 – 6,130.00
52-Week Range4,960.00 – 10,950.00
Volume3.01K
Market Cap26.23B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.87
50-Day Avg5,345.60
200-Day Avg6,861.55

About

HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiotics Plus. It also provides CDMO, contract development organization and contract research organization, contract manufacturing organization, quality assurance system, and funding services. Its products are used for antioxidant/skin health/immune function, female menopausal health/skin moisturizing/UV care, liver health, cartilage and joint health/bone health, body fat reduction/energy metabolism, brain health/blood circulation improvement, and gut health applications. The company was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOHae-Yeon Yi
  • Employees75
  • Headquarters36, Dongsanjae-gil, Hwaseong-si, South Korea, Korea
  • Websitehttps://www.hlscience.com

Leadership

  • Hae-Yeon YiCEO & Director · b. 1968
  • Mr. Sok-Hun KangChief Finance Officer, Managing Director and Director · b. 1959
  • Dong-Ryul LeeSenior Managing Director of Management Support and Director · b. 1979

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue17.20B23.71B40.93B40.20B64.11B128.26B143.04B104.38B52.76B25.59B17.66B16.71B
Growth (%)-+37.85%+72.65%-1.78%+59.48%+100.07%+11.52%-27.03%-49.45%-51.50%-30.97%-5.43%
Cost of Revenue5.14B6.43B11.77B12.04B18.97B31.32B33.22B26.64B16.25B9.69B10.34B8.14B
Gross Profit12.06B17.27B29.15B28.15B45.14B96.94B109.81B77.74B36.51B15.90B7.32B8.56B
Gross Margin70.12%72.87%71.23%70.04%70.42%75.58%76.77%74.48%69.20%62.13%41.44%51.26%
Operating Expense9.57B14.30B22.39B22.91B32.89B73.26B86.18B62.97B37.11B20.59B17.18B19.61B
Operating Income2.49B2.98B6.76B5.25B12.25B23.68B23.63B14.77B-603.66M-4.69B-9.86B-11.05B
Operating Margin14.48%12.55%16.52%13.05%19.11%18.47%16.52%14.15%-1.14%-18.34%-55.84%-66.15%
EBITDA--------2.62B-97.85M-5.72B-8.45B
EBITDA Margin--------4.97%-0.38%-32.36%-50.58%
Net Income2.13B3.53B6.07B4.94B10.86B19.74B19.64B13.54B1.59B-1.38B-7.88B-11.92B
Net Income Margin12.39%14.90%14.84%12.29%16.95%15.39%13.73%12.97%3.02%-5.38%-44.59%-71.34%
R&D596.18M305.97M----1.00B915.20M1.02B1.22B1.17B1.08B
R&D as % of Total Revenue3.47%1.29%----0.70%0.88%1.94%4.75%6.61%6.46%
Interest Expense0000001.97M1.34M229.00K19.00K14.82M-
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.08%-

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.89B17.39B54.58B57.74B71.41B94.42B107.06B117.87B108.82B105.97B97.78B85.04B
Total Liabilities3.63B2.86B4.39B4.60B8.42B13.21B11.22B10.61B4.60B3.38B3.23B2.27B
Total Equity10.26B14.53B50.19B53.14B62.99B81.21B95.84B107.26B104.22B102.42B94.54B82.61B
Cash1.74B3.29B2.00K3.80B8.64B14.47B7.54B2.97B3.62B2.32B16.23B1.78B
Total Debt-----56.45M23.45M-----

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.31B3.10B5.53B5.83B13.02B21.38B14.97B10.56B3.95B-1.96B-3.59B-7.05B
Investing Cash Flow-864.07M-591.17M-30.63B-8.39B-7.23B-14.02B-15.45B-14.63B1.35B933.39M17.07B-
Financing Cash Flow-900.00M-960.90M29.59B-1.43B-947.00M-1.53B-4.86B-2.11B-4.65B-280.18M431.00M-
Capital Expenditure378.21M691.75M4.27B4.99B502.80M7.51B1.38B18.25B11.34B2.47B1.24B523.47M
Free Cash Flow------14.41B-8.27B-8.03B-4.43B-4.83B-7.57B
Dividends Paid-2.02B--1.01B1.52B2.02B2.00B2.10B0--
FCF to OCF------96.28%-78.37%-203.04%226.53%134.63%107.43%
Dividend Paid to FCF------14.04%-24.17%-26.14%0.00%--

Earnings

Report DateMay 15, 2017Aug 11, 2017Nov 14, 2017Feb 7, 2018May 8, 2018Jul 31, 2018Oct 29, 2018Feb 11, 2019May 13, 2019Aug 7, 2019Oct 23, 2019Feb 7, 2020May 11, 2020Aug 13, 2020Oct 29, 2020Mar 15, 2021May 14, 2021Jul 29, 2021Nov 12, 2021Feb 7, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 20, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------
EPS Actual343.42216.00124.00337.44469.07478.61549.29547.97861.561150.02919.13783.45976.75818.721026.26905.43551.00984.00506.00562.04300.9078.9026.51-105.34-151.88-4.83-70.21-43.07-321.49-247.60-198.23-779.23-486.89-520.28-436.21-896.61-364.60-492.47
Surprise--------------------------------------
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-market---Pre-market--------------

Key Statistics & Ratios

Market Cap26.23B
Enterprise Value-6.92B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.53
Price / Book0.35
Revenue (TTM)10.44B
Gross Profit (TTM)3.25B
EBITDA-7.72B
Profit Margin-106.83%
Operating Margin-111.62%
Return on Equity-13.36%
Return on Assets-7.26%
Shares Outstanding5.09M
Shares Float1.59M
Beta0.87
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
400.00Dec 28, 2022
20211×
400.00Dec 29, 2021
20201×
400.00Dec 29, 2020
20191×
380.95Dec 27, 2019
20181×
285.71Dec 27, 2018
20171×
190.48Dec 27, 2017

Stock Splits

  • Dec 29, 202021:20